From: Glaucoma and risk factors three years after congenital cataract surgery
Group 1 | Group 2 | Group 3 | P-value 1 | P-value 2 | P-value 3 | * P-value 1 | * P-value 2 | * P-value 3 | |
---|---|---|---|---|---|---|---|---|---|
Eyes, n | 111 | 85 | 63 | ||||||
Right eye, n | 57 | 43 | 34 | ||||||
Unilateral cataract, n (%) | 61 (55.0) | 22 (25.9) | 7(11.1) | < 0.001 | < 0.001 | 0.025 | |||
IOL implantation, n | |||||||||
In-the-bag | 109 | 68 | – | ||||||
Sulcus | 2 | 17 | – | ||||||
History of prematurity, n (%) | 7 (6.3) | 13 (15.3) | 4 (6.4) | 0.039 | 1.000 | 0.092 | 0.287 | 0.518 | 0.175 |
FHCC, n (%) | 7 (6.3) | 12 (14.1) | 8 (12.7) | 0.067 | 0.149 | 0.803 | 0.525 | 0.838 | 0.621 |
PFV, n (%) | 16 (14.4) | 17(20.0) | 10(15.9) | 0.300 | 0.795 | 0.520 | 0.015 | 0.037 | 0.566 |
Age at surgery (months), Median (IQR) | |||||||||
Primary surgery | 34.0 (15.0–46.0) | 4.0 (3.0–5.0) | 3.0 (2.0–4.0) | < 0.001 | < 0.001 | 0.008 | < 0.001 | < 0.001 | 0.045 |
Secondary surgery | – | 34.0 (24.0–37.0) | – | ||||||
Follow-up (months), Median (IQR) | 39.0 (29.0–53.0) | 50.0 (44.0–62.0) | 35.0 (27.0–44.0) | < 0.001 | 0.050 | < 0.001 | < 0.001 | 0.030 | < 0.001 |
IOP (mmHg), Mean ± SD | |||||||||
Baseline 1 | 12.9 ± 3.1 | 12.4 ± 2.6 | 10.8 ± 2.7 | 0.176 | < 0.001 | < 0.001 | 0.292 | < 0.001 | 0.002 |
Baseline 2 | – | 13.9 ± 2.7 | – | ||||||
Latest follow-up | 14.6 ± 3.1 | 16.8 ± 4.0 | 14.4 ± 3.1 | < 0.001 | 0.635 | < 0.001 | 0.001 | 0.503 | < 0.001 |
Pre-op HCD (mm), Mean ± SD | 10.4 ± 0.6 | 9.4 ± 0.7 | 9.4 ± 1.0 | < 0.001 | < 0.001 | 0.982 | < 0.001 | < 0.001 | 0.903 |
Pre-op CCT (μm), Mean ± SD | 541.1 ± 44.5 | 564.8 ± 49.7 | 574.6 ± 46.9 | 0.001 | < 0.001 | 0.230 | 0.012 | 0.002 | 0.359 |
Pre-op ACD (mm), Mean ± SD | 2.9 ± 0.6 | 2.3 ± 0.4 | 2.4 ± 0.5 | < 0.001 | < 0.001 | 0.782 | < 0.001 | < 0.001 | 0.874 |
Pre-op LT (mm), Mean ± SD | 3.7 ± 0.9 | 3.4 ± 1.0 | 3.1 ± 1.1 | 0.185 | 0.003 | 0.095 | 0.337 | 0.070 | 0.218 |
Pre-op AL (mm), Mean ± SD | 21.5 ± 2.0 | 18.7 ± 1.1 | 17.9 ± 1.5 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.006 |
Glaucoma, n (%) | 0 (0) | 6 (7.1) | 4 (6.3) | 0.006 | 0.016 | 1.000 | 0.025 | 0.144 | 0.894 |
Glaucoma suspect, n (%) | 0 (0) | 10 (11.8) | 1 (1.6) | < 0.001 | 0.362 | 0.025 | 0.010 | 0.304 | 0.058 |
Glaucoma-related adverse events, n (%) | 0 (0) | 16 (18.8) | 5 (7.9) | < 0.001 | 0.006 | 0.061 | < 0.001 | 0.070 | 0.127 |
Steroid-induced ocular hypertension, n (%) | 5 (4.5) | 17 (20.0) | 5 (7.9) | 0.001 | 0.499 | 0.041 | 0.009 | 0.211 | 0.038 |